Pregnancy-associated atypical hemolytic-uremic syndrome (p-aHUS) refers to a pregnancy that leads to thrombotic microangiopathy (TMA). This disease is associated with adverse maternal outcomes. We encountered a case of p-aHUS, in which treatment with ravulizumab, a long-acting C5 inhibitor, resulted in a favorable clinical course and recovery of renal function. The patient was a 31-year-old woman with no apparent medical history. She developed TMA on the third postpartum day and was initially treated with steroids, plasma exchange, and hemodialysis (HD). On the seventh day of treatment initiation, she was diagnosed with p-aHUS, and treatment with ravulizumab was started. Following administration, her platelet count increased, and her acute kidney injury improved. Consequently, HD was discontinued after six sessions, and the patient was discharged on the 28th day of treatment initiation and continued her recovery at home. Similar to eculizumab, ravulizumab is an effective treatment for p-aHUS. Early administration of ravulizumab after diagnosis of p-aHUS may contribute to favorable clinical outcomes and recovery of renal function, as observed in the present case.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10942846PMC
http://dx.doi.org/10.7759/cureus.54207DOI Listing

Publication Analysis

Top Keywords

pregnancy-associated atypical
8
p-ahus treatment
8
treatment ravulizumab
8
favorable clinical
8
recovery renal
8
renal function
8
day treatment
8
treatment initiation
8
ravulizumab
5
p-ahus
5

Similar Publications

Background: Postpartum hemorrhage is considered a risk factor for pregnancy-associated complement-mediated hemolytic uremic syndrome (CM-HUS; previously known as atypical hemolytic uremic syndrome) but has not been systematically studied.

Objectives: To systematically examine the role of postpartum hemorrhage in precipitating CM-HUS and to describe the characteristics of postpartum hemorrhage-associated CM-HUS, its prognosis and recommended management.

Methods: A systematic review of individual participant data from case series and reports in addition to a case series from our institution.

View Article and Find Full Text PDF

Spontaneous coronary artery dissection (SCAD) is an uncommon form of non-atherosclerotic coronary artery disease, characterized by a sudden tear in coronary artery layers. Pregnancy-associated SCAD (P-SCAD) is a rare variant occurring during pregnancy or postpartum. We present a case of P-SCAD in a 31-year-old postpartum female who experienced generalized tonic-clonic seizures along with ventricular fibrillation.

View Article and Find Full Text PDF

Pregnancy introduces a multitude of changes in the body, including hormonal fluctuations and metabolic changes, which can lead to atypical ocular signs and symptoms. Ocular manifestations range from fluctuations in vision, to microstructural changes in the retina and choroid, to dry eye disease. This narrative review highlights the range of pregnancy-related effects on the eye and vision that are likely to present in the context of routine eyecare.

View Article and Find Full Text PDF
Article Synopsis
  • Thrombotic microangiopathy (TMA) is a dangerous condition that can happen during pregnancy, causing issues like low platelets and anemia.
  • A woman in her 40s had to have an emergency C-section because she was very sick, and later developed a rare pregnancy-related type of TMA called atypical HUS (aHUS).
  • Treatment with a special medicine called eculizumab helped her recover, showing that early diagnosis and help from medical labs is super important for this disease.
View Article and Find Full Text PDF

Introduction: In pregnancy-related atypical hemolytic uremic syndrome (p-aHUS), transferring recommendations for treatment decisions from nonpregnant cohorts with thrombotic microangiopathy (TMA) is difficult. Although potential causes of p-aHUS may be unrelated to inherent complement defects, peripartal complications such as postpartum hemorrhage (PPH) or (pre)eclampsia or Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP) syndrome may be unrecognized drivers of complement activation.

Methods: To evaluate diagnostic and therapeutic decisions in the practical real-life setting, we conducted an analysis of a cohort of 40 patients from 3 German academic hospitals with a diagnosis of p-aHUS, stratified by the presence ( = 25) or absence ( = 15) of PPH.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!